GSE159052
Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that can be Exploited by Targeting DNA Polymerase Epsilon
RNAseq data for MDA-MB-231, CAMA-1, and MCF7 cells expressing shPOLE and either a vector control or cDNA POLE rescue Overall design: Cell Lines express an shRNA targeting DNA Polymerase epsilon (POLE) and either a POLE cDNA or vector control.